Schedule an Appointment

Cancer Questions

Circle of Hope Blog

Lymphoma Program

Our Program

Dr. Martha J.
Glenn

Dr. Ahmad
Halwani

Dr. Deborah
Stephens

Dr. John
Sweetenham

Our Physicians

Our Hospital Designations

The lymphoma program provides access to current state-of the-art treatments and clinical trials beyond classical cytotoxic chemotherapy regimens. Treatment options offered today include novel targeted therapies and allogeneic bone marrow transplantation to optimize patient outcomes. 

Diseases treated:

  • Hodgkin’s Lymphoma (HL)
  • Non-Hodgkin’s Lymphoma (NHL-all subtypes)
    • Diffuse Large B-cell Lymphoma (DLBCL)
    • Follicular Lymphoma (FL)
    • Mantle Cell Lymphoma (MCL)
    • Marginal Zone Lymphoma (MZL-all subtypes)
      • Nodal
      • Extranodal 
      • Splenic
      • Mucosa-associated Lymphoid Tissue (MALT)
    • Primary Mediastinal B-cell Lymphoma
    • T-cell lymphoma (TCL-all subtypes)
      • Anaplastic Large Cell
      • Angioimmunoblastic
      • Cutaneous
      • Extranodal NK/Tcell
      • Peripheral T-cell, not otherwise specified
    • Plasmablastic Lymphoma
  • Chronic Lymphocytic Leukemia (CLL)
  • Waldenstrom’s Macroglobulinemia (WM)
  • Large Granular Lymphocytic (LGL) Leukemia
  • Hairy Cell Leukemia (HCL)